|
 |
| December 13, 2004 |
Neotropix Attracts $10 Million Series A Round For Development of Novel Virotherapies to Treat Cancer |
| November 22, 2004 |
Transport Pharmaceuticals Secures $27M in Series D Financing |
| September 23, 2004 |
BioAdvance Ventures Announces Closing of $26 Million Early Stage Life Sciences Fund |
| September 7, 2004 |
Quaker BioVentures Closes Innaugeral Fund With $280 Million Under Management |
| August 31, 2004 |
EDA, Quaker BioVentures Will Partner Iin New Venture Fund to Invest $40 Million in N.J.-Based Emerging Biotech Companies |
| July 07, 2004 |
Quaker BioVentures Appoints Biotechnology Industry Veteran to Advisory Board |
| June 1, 2004 |
Nucleonics Adds Additional $8.3 Million to Series B Financing, Bringing Total Raised this Round to $49.2 Million |
| April 28, 2004 |
LLR Partners and Quaker BioVentures Continue Investment Momentum with $28M Equity Investment in Medmark |
| April 14, 2004 |
Discovery Laboratories Files New Drug Application with the FDA |
| March 31, 2004 |
EXIMIAS Pharmaceutical Corporation Announces $63.5 Million Private Placement |
| March 11, 2004 |
BioRexis Completes $30 Million Series B Financing |
|
|
